RE:RE:ask yourself that's amazing that Hexo is the only LP with an outperform rating. Wow. Riv Capital is like better run version of sundial bank and loan.
CIBC's target price charges with their analyst recommendation are as follows:
- Aurora Cannabis: $7 from $8, underperform
- Cronos Group: US$7.50 from US$8.50, neutral
- Hexo: $5 from $6, outperform
- Organigram: $3.50 from $4, neutral
- RIV Capital: $2.25 from $2.50, outperform
- Tilray: US$14 from US$17, neutral
- Canopy Growth: $22 from $27, neutral